First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study - Piedra, Aida; Martínez-Recio, Sergio; Hernández, Ainhoa; Morán, Teresa; Arriola, Edurne; Recuero-Borau, Jordi; Cobo, Manuel; Cordeiro, Patricia; Mosquera, Joaquín; Fernández, Manuel; García-Campelo, Rosario; Calles, Antonio; et al. (Frontiers in Oncology, 2024)